Exchange Bulletin
Knight Therapeutics Inc. (GUD) To Trade On Toronto Stock Exchange
Knight Therapeutics Inc. - An application has been granted for the original listing in the Industrial category of 86,023,370 common shares ("Shares") of Knight Therapeutics Inc. (the "Company"), of which 77,764,640 are issued and outstanding and 8,258,730 are reserved for issuance.
The Shares will be listed and posted for trading at the opening of business on Tuesday, April 29, 2014.
Stock Symbol: "GUD" | CUSIP: 499053 10 6 | Trading Currency: CDN$ |
Designated Market Maker: | Jones, Gable & Company Limited |
Other Markets: | The Shares have been listed on TSX Venture Exchange since February 27, 2014 and have been trading under the symbol "GUD". The Shares will be delisted from TSX Venture Exchange on April 29, 2014, upon commencement of trading on Toronto Stock Exchange. |
Head Office Address: | 376 Victoria Avenue Suite 220 Westmount, Québec H3Z 1C3 |
Email Address: | jkadanoff@gud-knight.com |
Website: | www.gud-knight.com |
Head Office Telephone Number: | (514) 484-4483 |
Fax Number: | (514) 481-4116 |
Investor Relations: | Jonathan Ross Goodman Tel.: (514) 484-4483 jgoodman@gud-knight.com Jeffrey Kadanoff Tel.: (514) 484-4483 jkadanoff@gud-knight.com |
Incorporation: | The Company was incorporated under the Canada Business Corporations Act on November 1, 2013. |
Fiscal Year End: | December 31 |
Chief Financial Officer and Corporate Secretary: | Jeffrey Kadanoff |
Transfer Agent & Registrar: | Computershare Investor Services Inc., at its principal offices in Montréal and Toronto. |
Dvidends: | The Company does not intend to pay dividends in the foreseeable future. |